Arkolith/Insider Trading/ENTA/Form 4

Luly Jay R.

President and CEO, DirectorENANTA PHARMACEUTICALS INC (ENTA) · full profile →Form 4 · filed Dec 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$67K
Net Open-Market Flow
-$67K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2025Sell(S)5K$14.23$67K858K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002064832-25-000057) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML